It was cake for everyone at the Cure Day Hospital in Somerset West when Cohsasa handed over a second three-year accreditation certificate to Carmen Bester, the hospital manager, and staff. And what a cake it was!
Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Clinically validated lipid nanoparticle (LNP) delivery technology will further strengthen Bayer's gene therapy portfolio High potency ionizable lipid technology and LNP carriers to be developed
Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics. Acuitas’ LNP technology will support Bayer’s in vivo gene editing and protein replacement programs by specifically delivering .